Risk-Benefit Assessment [resa]
Dopamine Agonists [phsu]
Proven [qlco]
Efficacy [qlco]
Parkinson Disease [dsyn]
Pd [elii]
PREVENT [phsu]
Motor [ftcn]
Complications [patf]
Dyscinesia [dsyn]
adjunct therapy [topp]
progress [ftcn]
Dopamine Agonists [phsu]
Additional [ftcn]
Benefits [qnco]
reduction [npop]
Depressive Symptoms [sosy]
treatment [ftcn]
Refractory [ftcn]
Tremor [sosy]
Side Effect [patf]
Profile [lbpr]
Levodopa [aapp, nsba, phsu]
Ergot [fngs]
Ergot [fngs]
treatment [ftcn]
Sudden onset [inpr]
Sleep [orgf]
Reduced [qlco]
impulse control [fndg]
Hallucination [mobd]
CARDIOVASCULAR [bdsy]
Fibrosis [patf]
Paper [mnob]
Specific [qlco]
Associations [menp]
Treatments [topp]
side effects [ftcn]
patient care [hlca]
choice [inbe]
depend [medd]
Risk-Benefit Assessment [resa]
Apply [hlca]
patient profile [hlca]
Physician [prog]
preference [idcn]
